Has Steven Roser, MD received payments from drug or device companies?

Yes. Drug and device makers reported $101,842 in general payments to Steven Roser, MD across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Roser, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Roser, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Roser, MD

Foot and Ankle Surgery · Boise, IDNPI 1992716872

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $77,401 of the $101,842 with a category attached, or 76.0%. 15 manufacturers reported payments, led by Vilex LLC at 38.7% of the total. Among foot and ankle surgery clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$101,842in general payments, 2019–2025

Across 104 payments — averaging $979.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vilex LLC$39K
Restor3d, Inc.$20K
Surgical Fusion Inc.$11K
Medline Industries LP$9K
Flower Orthopedics Coporation$7K
Medartis Inc.$6K
plus $11K from 9 others

$8,200in research payments, 2019–2025

Across 1 payment — averaging $8200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vilex LLC$8K

$36,025in ownership & investment interests, 2019–2025

Across 3 payments — averaging $12,008 each. An ownership or investment interest held by the physician or an immediate family member.

GLW, Inc$36K

What the payments were for

Consulting fees$77,40176%
Travel & lodging$19,54019%
Food & beverage$3,7014%
Education$1,2001%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vilex LLC	34	$39,398
Restor3d, Inc.	14	$19,680
Surgical Fusion Inc.	5	$10,610
Medline Industries LP	12	$8,505
Flower Orthopedics Coporation	4	$6,591
Medartis Inc.	6	$5,599
International Life Sciences	2	$4,500
Exactech, Inc.	8	$4,070
Steelhead Surgical Inc	2	$1,225
Stryker(2 entities)	11	$1,143
Treace Medical Concepts, Inc.	2	$232
Medical Device Business Services, Inc.	1	$122
Carbofix Orthopedics Inc	1	$83
Smith+Nephew	1	$72
Johnson & Johnson	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MEDLINE INDUSTRIES, INC.$30,263
HINTERMANN$26,323
DYNEX$10,072
APTUS$5,560
Fibula Nail, 3.5mm x 130mm, Titanium, Flex-Thread$4,500
Fibula Nail, 4.5mm x 130mm, Titanium, Flex-Thread$4,500
Fibula Nail, 4.5mm x 180mm, Titanium, Flex-Thread$4,500
Fibula Nail, 3.5mm x 180mm, Titanium, Flex-Thread$4,500
ZERO Profile Interlocking Cortex Screw, 2.7mm x 14mm, T8, Flex-Thread$4,500
FLEXBAND$4,500
VANTAGE$3,946
MEDLINE$2,025
REDEMPTION$1,349
MEDLINE UNITE$1,013
PENDING$1,013
INFINITY$740
MIS Distal Bunion - R&D$650
Optix$650
SUPRAFUSION$600
HOFFMANN$120

How this compares

$101,842 in reported general payments places this provider in the 90th percentile of 49 foot and ankle surgery providers in Idaho.

See all foot and ankle surgery providers in Idaho →

Medicare billing

Part B allowed, 2024

$62,154

Medicare patients

127

Services billed

463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	55	$568
Cephalexin	53	$483
Oxycodone Hcl	58	$233
Tramadol Hcl	66	$216

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Boise

Kaitlin NearyBoise$867K
Ryan KempBoise$8K
Travis KempBoise$7K
David ZarkouBoise$6K
Christopher DesutterBoise$4K
Scott BirdBoise$3K
Boyd AndrewsBoise$2K
Robert SwensenBoise$781
Dan RobinsonBlackfoot$170K
Kurt KinghornMeridian$150K

See the full list for Idaho →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →